China has approved its first orally administered GLP-1 weight-loss drug. GLP-1 drugs aid weight loss by mimicking a natural gut hormone that suppresses appetite and regulates blood sugar levels. China's National Medical Products Administration (NMPA) said on Thursday it had approved US-based pharmaceutical giant Eli Lilly's pills, marketed as 'Muyouda', to treat obese or overweight adults with at least one weight-related condition.
Oman Observer is now on the WhatsApp channel. Click here
